Published in Gene Therapy Weekly, October 23rd, 2003
This milestone represents the completion of one quarter of Lexicon's Genome5000 program for the discovery of new drug targets from the human genome. The company expects to continue the analysis of the remaining genes at a rate of approximately 1000 genes per year.
"We have now harvested more than 20 drug discovery programs from the human genome in major areas of medical need, including Alzheimer's disease, diabetes, obesity, cancer, inflammation, and heart disease," said Arthur T. Sands, MD, PhD, Lexicon's...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.